Sareum HoldingsFRA:RYH0 -4.37%32 Market Cap is €33.73 Mil as of Jun. 30, 2026. GuruFocus rates FRA:RYH0 with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,428 Biotechnology companies, Sareum Holdings ranks worse than 67.02% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sareum Holdings's share price for the quarter that ended in Dec. 2025 was €0.154. Sareum Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 138.07 Mil. Therefore, Sareum Holdings's market cap for the quarter that ended in Dec. 2025 was €21.26 Mil.
Sareum Holdings's quarterly market cap
declined
from Dec. 2024 (€37.73 Mil) to Jun. 2025 (€21.24 Mil) but then
increased
from Jun. 2025 (€21.24 Mil) to Dec. 2025 (€21.26 Mil).
Sareum Holdings's annual market cap
declined
from Jun. 2023 (€95.30 Mil) to Jun. 2024 (€51.60 Mil) and
declined
from Jun. 2024 (€51.60 Mil) to Jun. 2025 (€21.24 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sareum Holdings's Enterprise Value for Today is €30.85 Mil.
Sareum Holdings (FRA:RYH0) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sareum Holdings Market Cap Related Terms
Sareum Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Sareum Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:RYH0 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Sareum Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sareum Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sareum Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Sareum Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sareum Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sareum Holdings (FRA:RYH0) has a Market Cap of €33.73 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sareum Holdings and its competitors. According to the industry distribution chart, Sareum Holdings ranks #957 out of 1428 companies in the Biotechnology industry, placing it in the top 67%.
Is Sareum Holdings' Market Cap too high?
Sareum Holdings' current Market Cap is €33.73 Mil. Based on the distribution chart, Sareum Holdings ranks #957 out of 1428 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sareum Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sareum Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sareum Holdings ranks #957 out of 1428 companies for Market Cap. This places Sareum Holdings in the lower half of its industry. The industry median Market Cap is 119.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sareum Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sareum Holdings's current Market Cap is €33.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sareum Holdings stock overvalued right now?
Sareum Holdings (FRA:RYH0) has a current Market Cap of €33.73 Mil. The current Market Cap is €33.73 Mil. Sareum Holdings' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sareum Holdings (FRA:RYH0), the current Market Cap is €33.73 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
32GF Score
Get the complete analysis for FRA:RYH0
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RYH0 has been successfully added to your 
